QL1706 Combined With Chemotherapy and Anlotinib for the Treatment of Recurrent Ovarian Cancer
QL1706 Combined With Chemotherapy and Anlotinib for the Treatment of Recurrent Ovarian Cancer
Recruiting · NCT07286240 · Registry updated 2025-12-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| QL1706 Combined With Chemotherapy and Anlotinib for the Treatment of Recurrent Ovarian Cancer | Treatment of Recurrent Ovarian Cancer | Recruiting | Phase 2 | 2025-12-16 | NCT07286240 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Affiliated Cancer Hospital & Institute of Guangzhou Medical University | 33 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Lipai Chen | Guangzhou | China | 2 |